Search

The Basque SME located in Zamudio has invested heavily to equip itself with the equipment that will allow it to scale up the newly developed product

Promega PBMC ADCC Bioassay combines physiologically representative primary cells with reliable quantitative readout technology

The IUL’s reader, so-called iPeak®, capture, and process the image of the test guaranteeing the objectivity of the interpretation and increasing the sensitivity of the reader of rapid tests

Seven venture capital managers that specialize in the life sciences set up new workgroup as a key instrument for recovery

The compound is currently in Phase II Now has orphan designation in both U.S. and EU

Natac is looking for sales representatives

Primarily used in the Flavours & Fragrances (F&F) and Fine Chemicals industries, alcohol dehydrogenase is type of enzyme that helps convert alcohols into ketones/aldehydes with exceptionally high

The company will present recent clinical developments at the H.C. Wainwright Bioconnect, will participate in the 10th Annual Corporate Access Event of LifeSci Advisors 2021, in the open house of

Goal is to characterize the neuropsychiatric symptoms of patients harboring disease-causing SETD1A gene mutations. Also includes fundamental research in preclinical SETD1A models

The European Union has awarded a grant of 25.5€ million for the Accelerating Research and Innovation for Advanced Therapies (ARDAT) project.

The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called “Collaboration

Will also present at Jefferies 2020 Virtual London Healthcare Conference. CEO to participate in a Borderline Personality Disorder Day panel

Clinical Trial Application approved by Spanish Drug Agency

At Roche, Dr. Hoffmann was Head of Discovery Chemistry and Head of the Roche Postdoc Fellowship Program. Subsequently he served as Chief Scientific Officer and Executive VP at Zealand Pharma, Chief

In just over a year of history, the company has established itself as a leading driver in the biomedical innovation and entrepreneurship scene

Oryzon Genomics reported financial results for the third quarter of 2020 and provided an update on recent developments

“New technologies are a key element of digital transformation in the healthcare sector", Ricard Sagués, Business Development & Marketing Director at Asphalion

New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital

The OSD is an annual initiative whereby the company's employees devote part of their working hours to carry out activities that can have a positive impact on society